Astragalus Polysaccharide Alleviated Septic Associated Acute Kidney Injury Through Dual Mechanisms of RIPK1 ‐Dependent Necroptosis and Autophagy in Macrophage
Phytotherapy Research · 2026-06 · 40 (6) · 3150-3170
DOI: 10.1002/ptr.70309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 17.03.2026. Verfasst von Liwei Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Polysaccharides, Macrophages, Autophagy, Receptor-Interacting Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Natural Science Foundation of Shanxi Province, "1331 Project" Key Innovation (Cultivation) Team of Shanxi Province, 2021 Graduate Education Innovation program of Shanxi Provincial.
Abstract (Originalsprache)
Acute kidney injury (AKI) is a significant risk factor for high morbidity and disability in patients with sepsis, where systemic inflammation and immune dysregulation are key drivers of sepsis‐associated AKI (SA‐AKI). Astragalus polysaccharide (AP), a natural, low‐toxicity compound derived from Traditional Chinese Medicine Astragalus membranaceus (AM), possesses notable anti‐inflammatory and immunoregulatory activities. This study was therefore designed to investigate the role of AP in SA‐AKI, specifically focusing on its underlying anti‐inflammatory mechanism. To elucidate the core inflammatory pathology driving SA‐AKI, we established an LPS/zVAD‐induced endotoxemia mouse model and a corresponding LPS/zVAD‐stimulated Raw264.7 macrophage model. The renoprotective effect of AP and its underlying mechanisms were systematically investigated using H&E, ELISA, RT‐qPCR, Western blot, immunofluorescence, and siRNA silencing. In vivo results suggested that AP improved renal dysfunction and inflammation in LPS/zVAD‐induced septic mice. Furthermore, AP inhibited RIPK1/RIPK3/MLKL activation and restored autophagic flux in renal macrophages of SA‐AKI mice. In vitro, AP suppressed LPS/zVAD‐induced cell death and inflammatory cytokine expression by inhibiting the RIPK1/RIPK3/MLKL pathway. Concurrently, AP alleviated LPS/zVAD‐induced autophagy dysfunction by promoting TFEB nuclear translocation, an effect potentially mediated by RIPK1. Consistently, downregulation of TFEB expression in the kidney tissue of septic mice was reversed following AP administration. Collectively, AP demonstrated a therapeutic effect against SA‐AKI. Mechanistically, this effect was associated with the modulation of RIPK1, as AP concurrently inhibited necroptosis and restored autophagic flux via TFEB activation, both of which are RIPK1‐dependent processes. This dual modulation ultimately attenuated macrophage inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanxi Medical University, Taiyuan, China.
- Shanxi Provincial Key Laboratory of Drug Synthesis and Novel Pharmaceutical Preparation Technology, Shanxi Medical University, Taiyuan, China.
- Key Laboratory of Cellular Physiology, Ministry of Education, Department of Physiology, Shanxi Medical University, Taiyuan, China.
- Shanxi Engineering Research Center of Characteristic Drug Development, Shanxi Medical University, Taiyuan, China.
- Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, China.
- State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.
ORCID-Profile: Jiankuan Li, Jian Zhang
Förderung
- Natural Science Foundation of Shanxi Province
- "1331 Project" Key Innovation (Cultivation) Team of Shanxi Province
- 2021 Graduate Education Innovation program of Shanxi Provincial
- Shanxi Scholarship Council of China
- Provincial Doctoral Startup Research Fund of Shanxi Medical University
- Doctoral Startup Research Fund of Shanxi Medical University
- Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi
- Shanxi Province Higher Education "Billion Project" Science and Technology Guidance Project
Zitieren
APA
Wang, L., Zhang, W., Wang, Z., Zhang, W., Zhang, L., Li, J., Mao, Z., Zhang, J., Liang, T., Ge, R., Zhang, Y., Yan, C., Zhang, J., & Liang, T. (2026). Astragalus Polysaccharide Alleviated Septic Associated Acute Kidney Injury Through Dual Mechanisms of RIPK1 ‐Dependent Necroptosis and Autophagy in Macrophage. Phytotherapy Research, 40(6), 3150-3170. https://doi.org/10.1002/ptr.70309
Vancouver
Wang L, Zhang W, Wang Z, Zhang W, Zhang L, Li J, et al. Astragalus Polysaccharide Alleviated Septic Associated Acute Kidney Injury Through Dual Mechanisms of RIPK1 ‐Dependent Necroptosis and Autophagy in Macrophage. Phytotherapy Research. 2026;40(6):3150-3170. doi:10.1002/ptr.70309
BibTeX
@article{Wang2026,
author = {Wang, Liwei and Zhang, Wei and Wang, Zhenfang and Zhang, Weiqian and Zhang, Lu and Li, Jiankuan and Mao, Zhuoya and Zhang, Jingfang and Liang, Tingting and Ge, Rui and Zhang, Yu and Yan, Chaoqun and Zhang, Jian and Liang, Taigang},
title = {Astragalus Polysaccharide Alleviated Septic Associated Acute Kidney Injury Through Dual Mechanisms of RIPK1 ‐Dependent Necroptosis and Autophagy in Macrophage},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {6},
pages = {3150--3170},
doi = {10.1002/ptr.70309}
}
EUVIMED